Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas
Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas
Recruiting · NCT03805022 · Registry updated 2025-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Recruiting | Phase 3 | 2025-10-02 | NCT03805022 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chugai Pharma France | 1 |
| Institut Bergonié | 27 |
| Novartis | 114 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Georges François Leclerc | Dijon | France | 42 |
| Centre Léon Bérard | Lyon | France | 77 |
| CHRU Strasbourg | Strasbourg | France | 3 |
| CHU Dupuytren | Limoges | France | 13 |
| Insitut du Cancer | Montpellier | France | 1 |
| Institut Bergonie | Bordeaux | France | 53 |
| Institut Claudius Regaud | Toulouse | France | 5 |
| Institut de Cancérologie de l'Ouest - Site René Gauducheau | Saint-Herblain | France | 4 |
| Institut Gustave Roussy | Villejuif | France | 54 |
| Institut Paoli Calmettes | Marseille | France | 38 |